Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion
- 1 May 2005
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 67 (5), 1753-1761
- https://doi.org/10.1111/j.1523-1755.2005.00272.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injuryBritish Journal of Pharmacology, 2004
- Independent Pathways of P-Selectin and Complement-Mediated Renal Ischemia/Reperfusion InjuryThe American Journal of Pathology, 2004
- Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusionKidney International, 2002
- Cytokine Responses in Patients Undergoing Coronary Artery Bypass Surgery after Ischemic PreconditioningScandinavian Cardiovascular Journal, 2001
- Delayed Graft Function in Renal Transplantation: Etiology, Management and Long-term SignificanceJournal of Urology, 1996
- Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.JCI Insight, 1995
- Interleukin-8 and the chemokine familyInternational Journal of Immunopharmacology, 1995
- Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8Nature, 1993
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Neutrophil-mediated post-ischemic tubular leakage in the rat kidneyKidney International, 1989